Loreclezole hydrochloride structure
|
Common Name | Loreclezole hydrochloride | ||
|---|---|---|---|---|
| CAS Number | 2227372-56-5 | Molecular Weight | 310.99 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C10H7Cl4N3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Loreclezole hydrochlorideLoreclezole hydrochloride, an antiepileptic compound, is a selective GABAA receptor modulator and acts as a positive allosteric modulator of β2 or β3-subunit containing receptors[1][2]. |
| Name | Loreclezole hydrochloride |
|---|
| Description | Loreclezole hydrochloride, an antiepileptic compound, is a selective GABAA receptor modulator and acts as a positive allosteric modulator of β2 or β3-subunit containing receptors[1][2]. |
|---|---|
| Related Catalog | |
| Target |
GABAA receptor[1]. |
| In Vivo | Loreclezole (10, 25, 50 or 75 mg/kg, i.p. 60 min before measurement of seizure threshold ) results in a dosedependent rise in seizure threshold as measured by the dose of pentylenetetrazolrequired to produce a convulsion 60 min later. Loreclezole also has the least effect on loss of muscle tone as measured by the “pull-up” test[3]. Animal Model: Adult male Lister Hooded rats[3]. Dosage: 10, 25, 50 or 75 mg/kg. Administration: IP, 60 min before measurement of seizure threshold. Result: Resulted in a dosedependent rise in seizure threshold as measured by the dose of pentylenetetrazolrequired to produce a convulsion 60 min later. |
| References |
| Molecular Formula | C10H7Cl4N3 |
|---|---|
| Molecular Weight | 310.99 |
| InChIKey | AWKSVFLKVCVVFQ-MDZFRNKHSA-N |
| SMILES | Cl.ClC(=Cn1cncn1)c1ccc(Cl)cc1Cl |